Alpha Teknova, Inc. (TKNO): Price and Financial Metrics
TKNO Price/Volume Stats
| Current price | $1.71 | 52-week high | $4.27 |
| Prev. close | $1.80 | 52-week low | $1.62 |
| Day low | $1.71 | Volume | 18,948 |
| Day high | $1.93 | Avg. volume | 14,247 |
| 50-day MA | $2.69 | Dividend yield | N/A |
| 200-day MA | $2.70 | Market Cap | 69.81M |
TKNO Stock Price Chart Interactive Chart >
Alpha Teknova, Inc. (TKNO) Company Bio
Alpha Teknova, Inc. provides reagents for bioprocessing, bioproduction, and molecular diagnostics. The company's reagents enable the discovery, research, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. It offers liquid culture, dry culture, agar, and animal-free media, as well as pre-poured plates, biological buffers, solutions, chemicals, and various treated and certified waters. The company was founded in 1996 and is based in Hollister, California.
Latest TKNO News From Around the Web
Below are the latest news stories about ALPHA TEKNOVA INC that investors may wish to consider to help them evaluate TKNO as an investment opportunity.
Alpha Teknova Insiders Land Bargain With Gains Of US$1.4mInsiders who bought Alpha Teknova, Inc. ( NASDAQ:TKNO ) stock lover the last 12 months are probably not as affected by... |
Alpha Teknova (TKNO) Posted Better Than Expected Results in Q3Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The micro capitalization segment of the market proved the most challenging in the quarter with the Russell Micro Cap Index declining -7.93%. The Russell Micro Cap Growth Index fell further with a […] |
Alpha Teknova, Inc. (NASDAQ:TKNO) Q3 2023 Earnings Call TranscriptAlpha Teknova, Inc. (NASDAQ:TKNO) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Hello, and welcome to Alpha Tech Nova, Inc. Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to […] |
Teknova Reports Third Quarter 2023 Financial ResultsRaised $22.9 million of equity capital, paid down $10.0 million of long-term debtThird quarter 2023 total revenue was $8.2 million, down 24% from prior yearExpect 2023 revenue at the low end of previously announced guidance range of $37-40 million HOLLISTER, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecu |
Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023HOLLISTER, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2023, on Thursday, November 9, 2023, following the close of market. Teknova will host a webcast and conference call on Thursday, November 9 |
TKNO Price Returns
| 1-mo | -29.05% |
| 3-mo | -45.89% |
| 6-mo | -14.50% |
| 1-year | -14.07% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -54.16% |
| 2023 | -33.87% |
| 2022 | -72.46% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...